In yet major setback over a long seven-year legal battle, Supreme Court has today dismissed Swiss drugmaker Novartis AG’s plea to win patent protection for its blood cancer drug Glivec in India. Read more
In yet major setback over a long seven-year legal battle, Supreme Court has today dismissed Swiss drugmaker Novartis AG’s plea to win patent protection for its blood cancer drug Glivec in India. Read more
Advertise With Us || Contact Us || Priyacy Policy || Disclaimer || About Us || Our Editors
RSS